Initiated by the HUG then deployed at all Swiss University Cardiology Centers, the ELIPS Program aims to reduce the risk of recurrence after myocardial infarction.
It complements the existing broad care apparatus in the divisions of Cardiology, Heart Surgery, Angiology and Hemostasis.
Major advances are expected from the transfer of research towards care in therapies based on stem cells or in the development of bio-valves.
